Background illustration for clinical trials search

Paid Clinical Trials Bronx

Discover 4,047 paid clinical trials in Bronx, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

for
Non-Hodgkin Lymphoma Refractory/ Relapsed,
Location: New York NY, Buffalo NY, Nashville TN, St Louis MO,
Sponsor: LTZ Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07121946

Phase 1, Recruiting

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

for
Major Depressive Disorder (MDD),
Location: Cedarhurst NY, New York NY, Brooklyn NY,
Sponsor: Seaport Therapeutics

Sex: All

Age: 18 - 65

Code: NCT07065240

Phase 2, Recruiting

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

for
Glioblastoma, Recurrent Glioblastoma, GBM
Location: New York NY, Hershey PA, Baltimore MD, Cleveland OH,
Sponsor: CarThera

Sex: All

Age: 18+

Code: NCT05902169

Phase 3, Recruiting

Clinical Performance Evaluation of Native Whole Blood Samples of Patients on DOACs With the Perosphere ClotChek™

for
Coagulation
Location: Denville NJ, Danbury CT, Cooperstown NY, Rockville MD
Sponsor: Perosphere Technologies Inc.

Sex: All

Age: 18 - 70+

Code: NCT07012291

Recruiting

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

for
Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases,
Location: New York NY, Clifton Park NY, Toronto, Brentwood TN,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06858319

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Reduction or Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)

for
Mitral Regurgitation, Heart Disease
Location: New York NY, Thousand Oaks CA
Sponsor: InnovHeart

Sex: All

Age: 18+

Code: NCT07130994

Recruiting

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

for
Primary IgA Nephropathy
Location: New York NY
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT04557462

Phase 3, Recruiting

Music Intervention for Preterm Birth

for
Preterm Birth
Location: New York NY
Sponsor: Columbia University

Sex: Female

Age: 18 - 40

Code: NCT05945264

Recruiting

A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)

for
Multiple Myeloma
Location: New York NY, Charlottesville VA, Atlanta GA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07073547

Phase 1, Recruiting

HLA Demographics Study in Adults With Type 1 Diabetes

for
Diabetes Mellitus, Type I
Location: New York NY, Boston MA, Chapel Hill NC, Gainesville FL,
Sponsor: GentiBio, Inc

Sex: All

Age: 18 - 55

Code: NCT06860516

Recruiting

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

for
Bowel; Stricture
Location: New York NY, Piscataway NJ, Philadelphia PA, Boston MA,
Sponsor: GIE Medical

Sex: All

Age: 22+

Code: NCT05561127

Phase 3, Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: New York NY, Hackensack NJ, New Brunswick NJ,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase 2, Recruiting

Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

for
Keratinocyte Carcinoma, Basal Cell Carcinomas,
Location: New York NY
Sponsor: Bruce Robinson, MD

Sex: All

Age: 18+

Code: NCT07010692

Phase 1, Phase 2, Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

for
Agitation, Alzheimer Disease
Location: Manhasset NY, New Windsor NY, Toms River NJ,
Sponsor: Celgene

Sex: All

Age: 55 - 70+

Code: NCT06808984

Phase 2, Recruiting

Methamphetamine Cue-reactivity

for
Methamphetamine Use Disorder
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: Male

Age: 18 - 60

Code: NCT07086014

Recruiting

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

for
Pancreatic Neuroendocrine Tumor (pNET),
Location: New York NY, Philadelphia PA, Boston MA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06943755

Phase 2, Phase 3, Recruiting

A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell Lymphoma

for
Lymphoma
Location: New York NY, Harrison NY, Uniondale NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07030699

Phase 2, Recruiting

Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers

for
Post Traumatic Stress Disorder
Location: New York NY, Piscataway NJ, Durham NC, Fremont OH,
Sponsor: University of Michigan

Sex: All

Age: 18+

Code: NCT05751473

Recruiting

Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

for
Low-grade Upper Tract Urothelial Carcinoma
Location: New York NY, Philadelphia PA, Jacksonville FL,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06668493

Phase 1, Phase 2, Recruiting

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for
Multiple Myeloma, Newly Diagnosed Multiple Myeloma
Location: New York NY, Hackensack NJ, Stony Brook NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06679101

Phase 3, Recruiting